申请人:Zhang Colin
公开号:US08436008B2
公开(公告)日:2013-05-07
The present invention relates to substituted heterocyclic compounds of Formula I:
or pharmaceutically acceptable salts or N-oxides or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are histamine H4 receptor inhibitors/antagonists useful in the treatment of histamine H4 receptor-associated conditions or diseases or disorders including, for example, inflammatory diseases or disorders, pruritus, and pain.
本发明涉及公式I的取代杂环化合物,或其药学上可接受的盐、N-氧化物或季铵盐,其中组分成员在此提供,以及它们的组合物和使用方法,这些方法是组织胺H4受体抑制剂/拮抗剂,有用于治疗与组织胺H4受体相关的疾病或疾病或疾病,包括例如,炎症性疾病或疾病,瘙痒和疼痛。